HY-10330-10mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
HY-10330-5mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
HY-10330-50mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
HY-10330A-10mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
HY-10330A-100mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
HY-10330A-25mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
HY-10330A-5mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
HY-10330A-50mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
HY-10408-10mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-2mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-5mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-50mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-13016-10mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
HY-13016-100mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
HY-13016-200mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
HY-13016-5mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
HY-13016-50mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
HY-13016-500mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
HY-16749-1g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-10g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-10mg
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-100mg
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-2g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-20g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-200mg
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|